相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
Mahmoud H. Mosli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease
Gilles Boschetti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test
Shiho Takashima et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery
Emily K. Wright et al.
GASTROENTEROLOGY (2015)
Serial Fecal Calprotectin Measurements to Detect Endoscopic Recurrence in Postoperative Crohn's Disease: Is Colonoscopic Surveillance No Longer Needed?
Alain M. Schoepfer et al.
GASTROENTEROLOGY (2015)
Biomarkers of Inflammation in Inflammatory Bowel Disease
Bruce E. Sands
GASTROENTEROLOGY (2015)
High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis: What Is the Best Timing for Stool Sampling?
Margalida Calafat et al.
INFLAMMATORY BOWEL DISEASES (2015)
Disease Activity Assessment in IBD: Clinical Indices and Biomarkers Fail to Predict Endoscopic Remission
James D. Falvey et al.
INFLAMMATORY BOWEL DISEASES (2015)
Impact of disease location on fecal calprotectin levels in Crohn's disease
Krisztina B. Gecse et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
557 Silent Crohn's Disease: Elevated C Reactive Protein in Asymptomatic Patients and Risk of Subsequent Hospitalization
Eric J. Vargas et al.
GASTROENTEROLOGY (2015)
Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfa-Blocking Agents In Inflammatory Bowel Disease Patients In Deep Remission?
Pauliina Molander et al.
JOURNAL OF CROHNS & COLITIS (2015)
Fecal Calprotectin Concentrations in Healthy Children Aged 1-18 Months
Feng Li et al.
PLOS ONE (2015)
Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study
Anders Lasson et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2015)
The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn's disease
Takayuki Yamamoto
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2015)
Intestinal Stricture in Crohn's Disease
Chen-Wang Chang et al.
INTESTINAL RESEARCH (2015)
Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases
B. Pariente et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year
Luisa Guidi et al.
DIGESTIVE AND LIVER DISEASE (2014)
Biomarkers of Inflammatory Bowel Disease
Yi Fengming et al.
DISEASE MARKERS (2014)
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
Laurent Peyrin-Biroulet et al.
GUT (2014)
Fecal calprotectin one year after ileocaecal resection for Crohn's disease - A comparison with findings at ileocolonoscopy
Anders Lasson et al.
JOURNAL OF CROHNS & COLITIS (2014)
A prospective evaluation of the predictive value of faecal calprotectin in quiescent Crohn's disease
Graham D. Naismith et al.
JOURNAL OF CROHNS & COLITIS (2014)
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease
Toshifumi Hibi et al.
JOURNAL OF GASTROENTEROLOGY (2014)
The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease
Kaija-Leena Kolho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease
G. D. Naismith et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Evaluation of Mucosal Healing of Ulcerative Colitis by a Quantitative Fecal Immunochemical Test
Asuka Nakarai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors
Claudio Papi et al.
DIGESTIVE AND LIVER DISEASE (2013)
Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin
Taina Sipponen
DIGESTIVE DISEASES (2013)
Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review
Ioannis D. Kostakis et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis
Triana Lobaton et al.
INFLAMMATORY BOWEL DISEASES (2013)
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2013)
Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
Martine De Vos et al.
INFLAMMATORY BOWEL DISEASES (2013)
Faecal calprotectin but not C-Reactive Protein (CRP) or Crohn's Disease Activity Index (CDAI) may predict post-operative endoscopic recurrence of Crohn’s Disease
Konstantinos Papamichael et al.
Journal of Crohns & Colitis (2013)
A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease
Triana Lobatón et al.
Journal of Crohns & Colitis (2013)
Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care
Polychronis Pavlidis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Fistulizing Crohn's disease: Diagnosis and management
Krisztina Gecse et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2013)
Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study
Takayuki Yamamoto et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2013)
Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits
S. J. Whitehead et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2013)
C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
W. Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Comparative analysis of inflamed and non-inflamed colon biopsies reveals strong proteomic inflammation profile in patients with ulcerative colitis
Nina Aagaard Poulsen et al.
BMC GASTROENTEROLOGY (2012)
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Edouard Louis et al.
GASTROENTEROLOGY (2012)
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease
Ron Shaoul et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
Pauliina Molander et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
Ren Mao et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis
M. De Vos et al.
JOURNAL OF CROHNS & COLITIS (2012)
Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease
Clas-Goran af Bjorkesten et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Utility of faecal calprotectin analysis in adult inflammatory bowel disease
Lyn A. Smith et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease
L. S. Kiss et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
Matthias Jurgens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Fecal immunochemical test and small bowel lesions detected on capsule endoscopy: results of a prospective study in patients with obscure occult gastrointestinal bleeding
Zohar Levi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Peripheral Blood MicroRNAs Distinguish Active Ulcerative Colitis and Crohn's Disease
Feng Wu et al.
INFLAMMATORY BOWEL DISEASES (2011)
Crohn's Disease Activity Index Does Not Correlate with Endoscopic Recurrence One Year After Ileocolonic Resection
Miguel Regueiro et al.
INFLAMMATORY BOWEL DISEASES (2011)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
Dario Sorrentino et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
C-Reactive Protein and Disease Activity in Children with Crohn's Disease
Samantha Tilakaratne et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study
Lamia Kallel et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
Valle Garcia-Sanchez et al.
JOURNAL OF CROHNS & COLITIS (2010)
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Faecal calprotectin in children with clinically quiescent inflammatory bowel disease
Taina Sipponen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers
Shilpa Joshi et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease
C. A. Lamb et al.
BRITISH JOURNAL OF SURGERY (2009)
Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
Konstantinos Karmiris et al.
GASTROENTEROLOGY (2009)
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Increased Efficacy of Delayed-Release Mesalamine 4.8g/D (800mg Tablet) in Patients Previously Diagnosed with Ulcerative Colitis (UC)
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings
T. Sipponen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a Randomized trial
Gert Van Assche et al.
GASTROENTEROLOGY (2008)
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
M. Henriksen et al.
GUT (2008)
Predicting relapse in Crohn's disease: a biopsychosocial model
A. Bitton et al.
GUT (2008)
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Dorota Walkiewicz et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal Calprotectin, Lactoferrin, and Endoscopic Disease Activity in Monitoring Anti-TNF-alpha Therapy for Crohn's Disease
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Correlation between levels of C-reactive protein and clinical activity in Crohn's disease
S. Karoui et al.
DIGESTIVE AND LIVER DISEASE (2007)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease
Marco Scarpa et al.
DISEASES OF THE COLON & RECTUM (2007)
A simple biological score for predicting low risk of short-term relapse in Crohn's disease
Yann Consigny et al.
INFLAMMATORY BOWEL DISEASES (2006)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases
S Vermeire et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test
A Vilkin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
F Costa et al.
GUT (2005)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
